Promising Progression-Free Survival for Patients Low and Intermediate Grade Lymphoid Malignancies after Nonmyeloablative Umbilical Cord Blood Transplantation

Nonmyeloablative hematopoietic cell transplantation (HCT) has been used to treat patients with advanced or high-risk lymphoid malignancies. We studied 65 patients (median age 46 years) receiving an umbilical cord blood (UCB) graft after a single conditioning regimen consisting of cyclophosphamide (5...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Brunstein, Claudio G., Cantero, Susana, Cao, Qing, Majhail, Navneet, McClune, Brian, Burns, Linda J., Tomblyn, Marcie, Miller, Jeffrey S., Blazar, Bruce R., McGlave, Philip B., Weisdorf, Daniel J., Wagner, John E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582655/
https://ncbi.nlm.nih.gov/pubmed/19167681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.11.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados